MarketInOut Stock Screener Log In | Sign Up
 

Natera Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 05/22/2026
Natera Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization29,402 mln
Float139 mln
Earnings Date07/30/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

0.25
Highly suspicious

1-Year Forecast

261
Strong upside

Relative Strength

86 / 100
Strongly outperforming

Debt / Equity

0.14
Very low leverage

ROE

-15.66
Negative

Business Description

Founded in 2003 and based in Austin, Texas, Natera develops and sells genetic testing services for use across oncology, women's health, and organ transplant care. Its tests help detect cancer recurrence, screen for hereditary conditions, support prenatal care, and monitor kidney and transplant health. The company works with hospitals, physician practices, research labs, and pharmaceutical companies, and also offers cloud-based software that allows partner labs to distribute its testing under license.

Key Fundamentals

EPS-1.62
ROE-15.66
RPS18.06
ROIC-31.76
ROA-10.96
EBITDA, mln-228
EV / EBITDA-118
EV / EBIT-95.28
Revenue, mln2,501
EV / Revenue10.75

Financial Strength

Altman Z-Score19.37
Piotroski F-Score 4 / 9
Beneish M-Score0.25
1-Year Target Price261
Short Ratio3.09
Short % of Float2.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.03% 91 / 100   
1 Month 1.02% 55 / 100   
2 Months -1.47% 37 / 100   
6 Months -6.94% 29 / 100   
1 Year 34.48% 75 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us